Babcock & Wilcox raised $230m at $18.50. Its $50m buyback can now reverse 44% of those new shares

Babcock & Wilcox Enterprises, Inc. (NYSE: BW) has an unusual capital-allocation opportunity only three months after raising approximately $230 million from investors. The company sold 12.43 million common shares at $18.50 apiece in May 2026, then authorised a share repurchase programme of up to $50 million in July. With BW ending the August 11 session around $9.19, roughly 50% below the offering price, the mathematics of buying back stock have changed dramatically.

At that price, a fully deployed $50 million authorisation could theoretically repurchase about 5.44 million shares, before transaction costs and assuming purchases could be made at roughly the same average price. That is equivalent to approximately 43.8% of the 12.43 million shares issued in May. In other words, Babcock & Wilcox could potentially reverse almost half of that recent share issuance while spending less than 22% of the gross cash it raised.

The arithmetic is attractive. The harder question is whether repurchasing shares is the best use of cash while Babcock & Wilcox is simultaneously scaling a capital-intensive artificial-intelligence data-center power business.

How much of the May share issuance could Babcock & Wilcox actually reverse?

The May offering generated approximately $230 million of gross proceeds from 12,432,432 shares sold at $18.50 each, including the full exercise of the underwriters’ option. Babcock & Wilcox said those funds were intended to support project and working capital, steam turbine and boiler capacity, AI data-center power projects, BrightLoop commercialization, potential acquisitions and balance-sheet strengthening.

Using BW’s latest approximately $9.19 share price as a simple reference point, $50 million could buy about 5.44 million shares. That would still leave the company a net issuer of roughly 6.99 million shares compared with the May transaction, ignoring other equity issuance, stock compensation and any price movement during actual repurchases.

There is nevertheless a striking price asymmetry. Babcock & Wilcox raised capital at $18.50 and could theoretically retire part of that same enlarged share base at a price about 50.3% lower. If the business ultimately delivers the earnings and cash flows implied by its expanding AI power opportunity, repurchasing shares at substantially below the issuance price could prove an efficient piece of capital recycling.

Why does the $50m buyback look different after BW fell to $9.19?

Babcock & Wilcox’s board authorised the programme on July 13, with repurchases expected to begin only after the second-quarter Form 10-Q was filed. That filing occurred on August 10. The authorisation does not require the company to spend the entire $50 million, has no fixed expiration date and can be suspended or discontinued, while purchases may also require customary approvals from senior lenders.

The programme therefore gives management optionality rather than creating a $50 million cash obligation.

That distinction has become particularly important because BW has been extraordinarily volatile. The shares reached an intraday high of $12.62 on August 11 before finishing around $9.19, giving the company a market capitalisation of roughly $1.42 billion. At that valuation, the full repurchase authorisation equals about 3.5% of the company’s equity value.

Executing heavily when the stock trades well below the May offering price would make more economic sense than treating the $50 million as a mechanical target irrespective of valuation. The company’s own authorisation explicitly allows timing to depend on share price, market conditions and other factors.

Does Babcock & Wilcox have enough cash to fund both growth and buybacks?

This is where the apparently simple buyback story becomes more complicated. Babcock & Wilcox reported $308.6 million of cash and cash equivalents at June 30, along with $39.4 million of current restricted cash and $34.8 million of long-term restricted cash. The commonly cited $382.8 million figure therefore includes $74.2 million that was classified as restricted.

A full $50 million repurchase would equal about 16.2% of the June-end unrestricted cash balance. Babcock & Wilcox also moved to redeem roughly $61.8 million of remaining December 2026 bonds in August, meaning the potential buyback plus that bond action together represent approximately $111.8 million, or more than 36% of the June-end cash and equivalents balance before considering subsequent operating cash flows.

The company is not facing the same balance-sheet position it did before the equity raise, but neither is the entire cash pile surplus capital. Babcock & Wilcox is advancing the $2.4 billion Base Electron project, reserving additional Siemens Energy turbine capacity and pursuing a wider data-center power pipeline. Those activities can require procurement deposits, payroll, manufacturing expenditure and working capital before customer milestone payments catch up.

Why operating cash flow may matter more than the headline cash balance

The first-half cash-flow statement provides the most important restraint on the buyback argument. Despite dramatic revenue growth, Babcock & Wilcox generated only $0.4 million of net operating cash during the first six months of 2026. Accounts receivable consumed $60.9 million of cash and contracts in progress absorbed another $17.8 million, although a $100.3 million increase in accounts payable provided a substantial offset.

That is not necessarily evidence of weakening operations. Large engineering and construction contracts frequently create significant timing differences between revenue recognition, supplier payments and customer receipts. It does, however, mean that the company’s $308.6 million cash position should not automatically be treated as excess cash available for repurchases.

The strongest version of the buyback case is therefore not that Babcock & Wilcox should immediately spend all $50 million. It is that management now possesses an unusually valuable option. The company issued stock at $18.50 when additional liquidity was strategically useful, and the subsequent share-price decline has created an opportunity to retire a meaningful portion of those shares at roughly half that price.

Whether exercising that option creates shareholder value will ultimately depend on what happens to project cash requirements. If Base Electron execution and future FastPower contracts begin producing stronger operating cash flow, buying shares materially below the May issuance price could look increasingly compelling. If new turbine commitments and AI infrastructure projects consume cash faster than customer payments arrive, preserving liquidity may prove more valuable than maximizing the repurchase.